X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (151052) 151052
Book Review (23735) 23735
Newsletter (21767) 21767
Publication (8021) 8021
Conference Proceeding (1818) 1818
Book Chapter (1064) 1064
Newspaper Article (704) 704
Dissertation (662) 662
Magazine Article (279) 279
Book / eBook (91) 91
Web Resource (51) 51
Reference (47) 47
Trade Publication Article (40) 40
Paper (13) 13
Data Set (7) 7
Government Document (6) 6
Journal / eJournal (6) 6
Transcript (4) 4
Presentation (2) 2
Poster (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (113327) 113327
humans (68419) 68419
animals (62224) 62224
male (54288) 54288
angiotensin (48437) 48437
female (34955) 34955
rats (34607) 34607
hypertension (28537) 28537
middle aged (20061) 20061
research (19951) 19951
angiotensin-ii (19329) 19329
angiotensin-converting enzyme inhibitors - therapeutic use (18273) 18273
angiotensin ii (17883) 17883
peripheral vascular disease (17425) 17425
blood pressure - drug effects (17051) 17051
angiotensin ii - pharmacology (17044) 17044
renin-angiotensin system (16016) 16016
adult (15940) 15940
cardiac & cardiovascular systems (14762) 14762
pharmacology & pharmacy (14759) 14759
aged (14743) 14743
hypertension - drug therapy (13765) 13765
blood pressure (12809) 12809
blood-pressure (11309) 11309
abridged index medicus (11129) 11129
physiology (10960) 10960
mice (10217) 10217
hypertension - physiopathology (10067) 10067
reports (9541) 9541
rats, sprague-dawley (9062) 9062
angiotensin-converting enzyme (9017) 9017
angiotensin-converting enzyme inhibitors - pharmacology (8709) 8709
risk factors (8631) 8631
urology & nephrology (8320) 8320
expression (8150) 8150
enzymes (8006) 8006
analysis (7978) 7978
antihypertensive agents - therapeutic use (7976) 7976
biochemistry & molecular biology (7923) 7923
heart failure (7565) 7565
oxidative stress (7479) 7479
physiological aspects (7477) 7477
cells, cultured (7330) 7330
renin-angiotensin system - drug effects (7272) 7272
renin - blood (7178) 7178
time factors (7073) 7073
ace inhibitors (6937) 6937
angiotensin ii - metabolism (6934) 6934
universities and colleges (6934) 6934
renin-angiotensin system - physiology (6752) 6752
dose-response relationship, drug (6730) 6730
endocrinology & metabolism (6380) 6380
treatment outcome (6211) 6211
renin (6182) 6182
rats, wistar (5908) 5908
angiotensin converting enzyme (5793) 5793
medicine, general & internal (5783) 5783
diabetes (5721) 5721
angiotensin receptor antagonists (5636) 5636
disease models, animal (5576) 5576
heart failure - drug therapy (5445) 5445
mortality (5442) 5442
aldosterone (5143) 5143
angiotensin-converting enzyme inhibitors (5074) 5074
captopril (5055) 5055
cell biology (5025) 5025
drug therapy, combination (4911) 4911
losartan (4876) 4876
medicine, research & experimental (4870) 4870
health aspects (4848) 4848
proteins (4843) 4843
in vitro techniques (4825) 4825
medical research (4794) 4794
angiotensin ii - physiology (4681) 4681
system (4648) 4648
drug therapy (4642) 4642
kidney (4609) 4609
heart (4594) 4594
activation (4568) 4568
inhibition (4556) 4556
dogs (4515) 4515
care and treatment (4496) 4496
inflammation (4466) 4466
myocardial-infarction (4457) 4457
antihypertensive agents - pharmacology (4435) 4435
disease (4411) 4411
heart-failure (4400) 4400
cells (4360) 4360
nitric oxide (4335) 4335
hypertrophy (4334) 4334
angiotensin ii type 1 receptor blockers - therapeutic use (4306) 4306
receptor (4255) 4255
fibrosis (4245) 4245
angiotensin ii - blood (4238) 4238
rodents (4228) 4228
adrenergic beta-antagonists - therapeutic use (4214) 4214
kidney - drug effects (4162) 4162
hypertension - complications (4134) 4134
signal transduction (4126) 4126
rat (4110) 4110
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (55) 55
Online Resources - Online (40) 40
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Periodical Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (162275) 162275
German (2579) 2579
Japanese (2334) 2334
French (1914) 1914
Russian (1723) 1723
Chinese (1283) 1283
Spanish (1127) 1127
Italian (763) 763
Polish (538) 538
Portuguese (418) 418
Korean (259) 259
Czech (184) 184
Hungarian (139) 139
Danish (116) 116
Dutch (102) 102
Swedish (96) 96
Romanian (87) 87
Norwegian (64) 64
Turkish (63) 63
Slovak (60) 60
Ukrainian (49) 49
Finnish (44) 44
Hebrew (32) 32
Bulgarian (29) 29
Serbian (27) 27
Croatian (25) 25
Persian (16) 16
Lithuanian (15) 15
Slovenian (7) 7
Bosnian (4) 4
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cardiac Failure, ISSN 1071-9164, 10/2017, Volume 23, Issue 10, p. S56
Journal Article
The FEBS Journal, ISSN 1742-464X, 04/2018, Volume 285, Issue 8, pp. 1375 - 1377
High resolution x‐ray structure of angiotensin‐1 converting enzyme incomplex with sampatrilat, by G. E. Cozier et al. (pp. 1477–1490). 
Angiotensin
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1368, pp. 231 - 238
Abstract Sleep apnea is characterized by increased sympathetic activity and is associated with systemic hypertension. Angiotensin (Ang) peptides have... 
Neurology | Intermittent hypoxia | Hypertension | Renin–angiotensin system | Sympathetic activity | Angiotensin-(1–7) | Renin-angiotensin system | Angiotensin-(1-7) | HEART-FAILURE | AWAKE RATS | CHEMOREFLEX ACTIVATION | NEUROSCIENCES | BLOOD-PRESSURE | CHRONIC-INTERMITTENT HYPOXIA | CARDIOVASCULAR REGULATION | ROSTRAL VENTROLATERAL MEDULLA | SYMPATHETIC-NERVE ACTIVITY | NITRIC-OXIDE | EPISODIC HYPOXIA | Sleep Apnea Syndromes - physiopathology | Angiotensin II - administration & dosage | Angiotensin Receptor Antagonists - pharmacology | Imidazoles - administration & dosage | Male | Peptide Fragments - pharmacology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 2 Receptor Blockers - pharmacology | Hypertension - etiology | Hypertension - prevention & control | Blood Pressure - drug effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Disease Models, Animal | Angiotensin II - pharmacology | Pyridines - administration & dosage | Microinjections | Peptide Fragments - administration & dosage | Losartan - pharmacology | Rats | Imidazoles - pharmacology | Angiotensin II - analogs & derivatives | Rats, Sprague-Dawley | Sleep Apnea Syndromes - complications | Paraventricular Hypothalamic Nucleus - drug effects | Animals | Angiotensin II Type 2 Receptor Blockers - administration & dosage | Pyridines - pharmacology | Losartan - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Index Medicus | Neurons | Carbon dioxide | Antagonists | Hypothalamus | Paraventricular nucleus | Muscimol | Sympathetic nervous system | Telemetry | Angiotensin receptors | Sleep disorders | Apnea | gamma -Aminobutyric acid A receptors | Angiotensin | Hypoxia | Blood pressure | cardiovascular regulation | peptides: anatomy and physiology | sympathetic activity | angiotensin-(1-7) | hypothalamic-pituitary-adrenal regulation | intermittent hypoxia | hypertension | renin-angiotensin system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | STRUCTURAL-FUNCTIONAL RELATIONSHIPS | CORTICAL INTERSTITIUM | BLOOD-PRESSURE CONTROL | EARLY NATURAL-HISTORY | RETINOPATHY | ANGIOTENSIN-CONVERTING ENZYME | NEPHROPATHY | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 07/2015, Volume 241, Issue 1, p. e44
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 3, pp. 211 - 221
Journal Article
Circulation, ISSN 0009-7322, 12/2004, Volume 110, Issue 25, pp. 3849 - 3857
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 10/2015, Volume 196, p. 54
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 02/2018, Volume 75, Issue 3, p. 87
Journal Article
Neuroscience Letters, ISSN 0304-3940, 05/2014, Volume 567, p. 51
acents Telmisartan markedly increased A[beta] generation. acents Losartan, valsartan and candesartan did not increase A[beta] generation. acents Olmesartan... 
Angiotensin
Journal Article
Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7650, pp. 327 - 332
Journal Article
Acta Biomaterialia, ISSN 1742-7061, 05/2014, Volume 10, Issue 5, p. 2147
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 07/2014, Volume 307, Issue 2, pp. H191 - H198
This study investigated sex differences in the sensitization of angiotensin (ANG) II-induced hypertension and the role of central estrogen and ANG-(1-7) in... 
Blood pressure | Angiotensin II | Angiotensin-(1-7) | Sex difference | Central nervous system | blood pressure | CONVERTING ENZYME | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | sex difference | BEHAVIORAL SENSITIZATION | RECEPTOR | 17-BETA-ESTRADIOL | central nervous system | EPIGENETICS | FEMALE RATS | angiotensin II | angiotensin-(1-7) | ALDOSTERONE/NACL-INDUCED HYPERTENSION | PERIPHERAL VASCULAR DISEASE | CENTRAL-NERVOUS-SYSTEM | SEX-DIFFERENCES | EXPRESSION | Estrogen Replacement Therapy | Angiotensin II - administration & dosage | Receptors, G-Protein-Coupled - metabolism | Male | RNA, Messenger - metabolism | Brain - metabolism | Peptidyl-Dipeptidase A - genetics | Receptor, Angiotensin, Type 1 - genetics | Time Factors | Peptidyl-Dipeptidase A - metabolism | Hypertension - prevention & control | Female | Blood Pressure - drug effects | Hypertension - genetics | Receptor, Angiotensin, Type 1 - drug effects | Receptors, G-Protein-Coupled - drug effects | Disease Models, Animal | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - drug effects | Ovariectomy | Brain - physiopathology | Peptide Fragments - administration & dosage | Angiotensin I - administration & dosage | Estradiol - administration & dosage | Gene Expression Regulation | Rats | Proto-Oncogene Proteins - genetics | Renin-Angiotensin System - genetics | Angiotensin II - analogs & derivatives | Telemetry | Rats, Sprague-Dawley | Hypertension - physiopathology | Hypertension - metabolism | Brain - drug effects | Animals | Receptor, Angiotensin, Type 1 - metabolism | Sex Factors | Renin-Angiotensin System - drug effects | Receptors, G-Protein-Coupled - genetics | Infusions, Intraventricular | Physiological aspects | Medicine, Experimental | Medical research | Properties | Renin-angiotensin system | Estrogen | Hypertension | Brain | Physiology | ACE inhibitors | Index Medicus | Cardiovascular Neurohormonal Regulation | angiotensin-(1–7), central nervous system
Journal Article
Hypertension: Journal of the American Heart Association, ISSN 0194-911X, 05/2004, Volume 43, Issue 5, pp. 970 - 976
ABSTRACT—We investigated in Lewis normotensive rats the effect of coronary artery ligation on the expression of cardiac angiotensin-converting enzymes (ACE and... 
Heart failure | Myocardial infarction | Angiotensin-converting enzyme | Receptors, angiotensin | Angiotensin | SYSTEM | heart failure | LOSARTAN | receptors, angiotensin | TYPE-2 RECEPTOR | myocardial infarction | HEART-FAILURE | RATS | BLOOD-PRESSURE | HYPERTROPHY | INHIBITION | PEPTIDES | angiotensin | PERIPHERAL VASCULAR DISEASE | ANTAGONISTS | angiotensin-converting enzyme | Receptor, Angiotensin, Type 1 - physiology | Tetrazoles - pharmacology | Angiotensin II - blood | Rats, Inbred Lew | Male | Coronary Vessels | Angiotensin II Type 1 Receptor Blockers | Peptidyl-Dipeptidase A - genetics | RNA, Messenger - biosynthesis | Angiotensin I - biosynthesis | Ligation | Enzyme Induction - drug effects | Myocardial Infarction - physiopathology | Imidazoles - therapeutic use | Cardiomyopathy, Hypertrophic - etiology | Peptide Fragments - genetics | Disease Models, Animal | Olmesartan Medoxomil | Losartan - pharmacology | Rats | Renin-Angiotensin System - physiology | Angiotensin I - blood | Carboxypeptidases - genetics | Imidazoles - pharmacology | Peptide Fragments - biosynthesis | Peptidyl-Dipeptidase A - biosynthesis | Myocardial Infarction - complications | Myocardium - enzymology | Animals | Myocardial Infarction - drug therapy | Angiotensin I - genetics | Losartan - therapeutic use | Carboxypeptidases - biosynthesis | Renin-Angiotensin System - drug effects | Tetrazoles - therapeutic use | Pyridines - pharmacology | Carboxypeptidases - physiology | Cardiomyopathy, Hypertrophic - prevention & control | Ventricular Remodeling - drug effects | Angiotensin II - physiology | Index Medicus
Journal Article
2001, Milestones in drug therapy., ISBN 376435982X, x, 187
Book
Molecular and Cellular Endocrinology, ISSN 0303-7207, 02/2014, Volume 382, Issue 2, p. 971
acents CB.sub.1 receptors mediate the gastroprotective effect of both 2-AG and Ang II (i.c.v.). acents Ang II (i.c.v.) induced gastroprotection is mediated by... 
Angiotensin
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2013, Volume 73, pp. 98 - 110
Telmisartan (TEL), an angiotensin type 1 receptor (AT1R) antagonist, has been reported to exert neuroprotective effect in animal models of Parkinson's disease... 
Angiotensin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.